Validation of the French Adaptation of the RAADS-R Scale : Scale of Asperger Syndrome Diagnosis
NCT ID: NCT02826148
Last Updated: 2016-07-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
324 participants
INTERVENTIONAL
2011-12-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Development of a Screening Questionnaire to Discriminate Autism Spectrum Disorder and Schizotypal Disorder, and Validation of the Danish Version of RAADS-R
NCT05213286
Prevalence and Healthcare Consumption of ASD Patients Using French Medico-administrative Data
NCT06409728
Validation Study of the Performance of the French Version of the Autism Mental Status Examination Scale as a Tool for Identifying Autism Spectrum Disorder in Adults
NCT06549179
Use of a Smartphone© Application to Study Autism Spectrum Disorders (ASD)
NCT03020277
Early Screening of Autism Spectrum Disorder in General and Pediatric Practices
NCT04274127
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with autism disorder
The RAADS-R scale is a self-administered questionnaire completed by the patient himself assisted by a clinician
RAADS-R scale
This scale is a self-administered questionnaire completed by the person himself assisted by a clinician
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RAADS-R scale
This scale is a self-administered questionnaire completed by the person himself assisted by a clinician
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Collection of the informed consent (patient or legal representant)
* Affiliation or recipient with the mode of social security
* Current reading skills evaluated by completion of the fact sheet attached to the scale
* Age limits to \> 18 years and \< 75 years
Specific criteria
* Group of adult subjects with autism
* Diagnosis of autism or Asperger syndrome established within the framework of a multidisciplinary evaluation (ADOS module 4 and/or ADI) using specific international classification criteria of rare diseases (CIM 10, DSM IV-R) (F84.0 et F84.5).
* Intellectual efficiency estimated by means of a psychometric tool standardized (WAIS, WASI) greater than or equal to 85
* Subjects not denying their symptoms
* Group of adult subjects with other psychiatric
* Diagnosis of an other psychiatric trouble established according to the specific international classification criteria of mental diseases (CIM 10, DSM IV).
* absence of pervasive developmental disorder diagnosis
* Subjects not denying their symptoms
* Group of adult subjects not carriers of development and/or psychiatric disorders
Exclusion Criteria
* Persons deprived of freedom by court order
Specific criteria
* Group of adult subjects with autism
* Refusal of participation
* absence of autism or Asperger syndrome diagnosis
* Group of adult subjects with other psychiatric
* Refusal of participation
* Pervasive developmental disorder diagnosis
* Group of adult subjects not carriers of development and/or psychiatric disorders
* Refusal of participation
* Diagnosis of cognitive development or psychomotor disorder, diagnosis of retard mental and/or psychiatric disorder.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Orange
UNKNOWN
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amaria BAGHDADLI, MD-PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Montpellier
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8747
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.